Alterations of Tumor Suppressor Genes and Allelic Losses in Human Hepatocellular Carcinomas in China

Cancer Research

Volumn 54, Issue 1, 1994, Pages 281-285

  Xie, J P ^c   Hampton, Lori L ^a   Wirth, Peter J ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Chinese PLA Inst of Liver Disease   (China)

^c CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1;

ALLELE; ARTICLE; CHINA; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 4; GENE MUTATION; HEPATITIS B; HETEROZYGOSITY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHINA; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 4; CODON; GENE DELETION; GENES, APC; GENES, P53; GENES, RETINOBLASTOMA; HEPATITIS B ANTIGENS; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0028084735     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Simonetti, R.G., Camma, C., Fiorello, F., Politi, F., D'amico, G., and Pagliaro, L. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig. Dis. Sci., 36: 962-972, 1991.
2. Tanaka, K., Hirohata, T., Koga, S., Sugimachi, K., Kanematsu, T., Ohryohji, F., Nawata, H., Ishibashi, H., Maeda, Y., Kiyokawa, H., Tokunaga, K., Irita, Y., Takashita, S., Arase, Y., and Nishino, N. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res., 51: 2842-2847, 1991.
3. Nalpas, B., Driss, F., Pol, S., Hamelin, B., Housset, C., Brechot, C., and Berthelot, P. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J. Hepatol., 12: 70-74, 1991.
4. Van Rensburg, S.J., Cook-Mozaffari, P., Van Schalkwyk, D.J., Van Der Watt, J.J., Vincent, T.J., and Purchase, I.F. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer, 51: 713-726, 1985.
5. Yeh, F.S., Yu, M.C., Mo, C.C., Luo, S., Tong, M.J., and Henderson, B.E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res., 49: 2506-2509, 1989.
6. Ozturk, M. p. 3 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338: 1356-1359, 1991.
7. Ross, R.K., Yuan, J.M., Yu, M.C., Wogan, G.N., Qian, G.S., Tu, J.T., Groopman, J.D., Gao, Y.T., and Henderson, B.E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339: 943-946, 1992.
8. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C. Mutational hotspot in the p. 3 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
9. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p. 3 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
10. Scorsone, K.A., Zhou, Y.Z., Butel, J.S., and Slagle, B.L. p. 3 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res., 52: 1635-1638, 1992.
11. Fujimoto, Y., Hampton, L.L., Luo, L., Wirth, P.J., and Thorgeirsson, S.S. Low frequency of p. 3 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. Cancer Res., 52: 1044-1046, 1992.
12. Weinberg, R.A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1145, 1991.
13. Solomon, E., Borrow, J., and Goddard, A.D. Chromosome aberrations and cancer. Science (Washington DC), 254: 1153-1160, 1991.
14. Marshall, C.J. Tumor suppressor genes. Cell, 64: 313-326, 1991.
15. Wang, H.P., and Rogler, C.E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet., 48: 72-78, 1988.
16. Buetow, K.H., Murray, J.C., Israel, J.L., London, W.T., Smith, M., Kew, M., Blanquet, V., Brechot, C., Redeker, A., and Govindarajah, S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 86: 8852-8856, 1989.
17. Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T., and Hirohashi, S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 6791-6794, 1990.
18. Zhang, W., Hirohashi, S., Tsuda, H., Shimosato, Y., Yokota, J., Terada, M., and Sugimura, T. Frequent loss of heterozygosity of chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn. J. Cancer Res., 81: 108-111, 1990.
19. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Hayada, H., Yagura, M., Matsubara, K., and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51: 89-93, 1991.
20. Simon, D., Knowles, B.B., and Weith, A. Abnormalities of chromosome 1 and loss of heterozygosity of 1p in primary hepatomas. Oncogene, 6: 765-770, 1991.
21. Walker, G.J., Hay ward, N.K., Falvey, S., and Cooksley, W.G.B. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res., 51: 4367-4370, 1991.
22. Slagle, B.L., Zhou, Y.Z., and Butel, J.S. Hepatitis B virus integration event in human chromosome 17p near the p. 3 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res., 51: 49-54, 1991.
23. Murakami, Y., Hayashi, K., Hirohashi, S., and Sekiya, T. Aberrations of the tumor suppressor p. 3 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51: 5520-5525, 1991.
24. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
25. Levine, A.J., Momand, J., and Finlay, C.A. The p. 3 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
26. Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B., and Erlich, H.A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (Washington DC), 239: 487-491, 1988.
27. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 6: 2766-2770, 1989.
28. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
29. Fujimoto, Y., Ishizaka, Y., Tahira, T., Sone, H., Takahashi, H., Enomoto, K., Mori, M., Sugimura, T., and Nagao, M. Possible involvement of c-myc but not ras genes in hepatocellular carcinomas developing after spontaneous hepatitis in LEC rats. Mol. Carcinog., 4: 269-274, 1991.
30. Sanger, F., Nicklen, S., and Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
31. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M., Sargeant, L., Krapcho, K., Wolff, E., Burt, R., Hughes, J.P., Warrington, J., McPherson, J., Wasmuth, J., Le Paslier, D., Abderrahim, H., Cohen, D., Leppert, M., and White, R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66: 589-600, 1991.
32. Yandell, D.W., and Dryja, T.P. Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am. J. Hum. Genet., 45: 547-555, 1989.
33. Matlashewski, G.J., Tuck, S., Pim, D., Lamb, P., Schneider, J., and Crawford, L.V. Primary structure polymorphism at amino acid residue 72 of human p. 3. Mol. Cell. Biol., 7: 961-963, 1987.
34. McDaniel, T., Carbone, D., Takahashi, T., Chumakov, P., Chang, E.H., Pirollo, K.F., Yin, J., Huang, Y., and Meltzer, S.J. The MspI polymorphism in intron 6 of p. 3 (TP53) detected by digestion of PCR products. Nucleic Acids. Res., 19: 4796, 1991.
35. Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., and Charnay, P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (Lond.), 281: 646-650, 1979.
36. Harris, C.C. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells, 2: 146-148, 1990.
37. Harris, C.C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. (Suppl.), 51: 5023s-5044s, 1991.